Please try another search
For the three months ended 30 June 2020, Pacgen Life Science Corp revenues decreased 45% to C$62K. Net loss increased 17% to C$99K. Revenues reflect Product sales decrease of 82% to C$17K. Higher net loss reflects General and administrative increase of 24% to C$69K (expense).
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Total Revenue | 0.06 | 0.05 | 0.08 | 0.11 |
Gross Profit | -0.03 | 0.03 | 0.04 | 0.05 |
Operating Income | -0.12 | -0.1 | -0.08 | -0.07 |
Net Income | -0.1 | -0.11 | -0.09 | -0.07 |
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Total Assets | 0.36 | 0.36 | 0.46 | 0.59 |
Total Liabilities | 0.41 | 0.32 | 0.3 | 0.35 |
Total Equity | -0.06 | 0.04 | 0.16 | 0.24 |
Period Ending: | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -0.08 | -0.03 | -0.05 | -0.08 |
Cash From Investing Activities | -0.02 | -0.02 | 0 | |
Cash From Financing Activities | 0.03 | -0.03 | -0.02 | -0.01 |
Net Change in Cash | -0.05 | -0.09 | -0.1 | -0.1 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review